Alector to Participate in Upcoming Healthcare Conferences
Alector will present fireside chats at Cantor and Morgan Stanley healthcare conferences, with live webcasts and 90-day replays for investors.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alector (ALEC) will participate in two investor healthcare conferences in New York in September 2026, each featuring a fireside chat with management.
The company joins the Cantor Global Healthcare Conference on September 10, 2026, at 2:10 p.m. ET and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026, at 7:00 a.m. ET. Live webcasts and 90-day replays will be accessible via the Investors “Events & Presentations” page on Alector’s website.
Details
News Market Reaction – ALEC
On Sep 4, the first trading day after this news, ALEC closed 1.99% below the previous close. Argus tracked a trough of -9.0% from its starting point during tracking. Our momentum scanner recorded 37 alerts in the available session data. Relative volume reached 4.6x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 4 session.
Key Figures
- Cantor conference date
- September 10, 2026
- Cantor Global Healthcare Conference 2026
- Cantor fireside chat time
- 2:10 p.m. ET
- September 10, 2026
- Morgan Stanley conference date
- September 15, 2026
- Morgan Stanley 24th Annual Global Healthcare Conference
- Morgan Stanley fireside chat time
- 7:00 a.m. ET
- September 15, 2026
- Webcast replay period
- 90 days
- Following the presentation dates
Historical Context
-
Lower collaboration revenue outweighed narrower net loss and continued ABC platform development.
-
Trial discontinuation and quarterly loss accompanied reduced cash balance and ongoing ABC development.
-
PROGRESS-AD was discontinued after interim analysis found it unlikely to meet its primary endpoint.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
blood-brain barrier medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of neurodegenerative diseases, today announced that management will participate in the following upcoming investor conferences:
Cantor Global Healthcare Conference 2026 (New York, New York)
Thursday, September 10, 2026, at 2:10 p.m. ET, fireside chat
Morgan Stanley 24th Annual Global Healthcare Conference (New York, New York)
Tuesday, September 15, 2026, at 7:00 a.m. ET, fireside chat
A live webcast of each fireside chat will be available on the "Events & Presentations" page within the Investors section of the Alector website at http://investors.alector.com. Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.
About Alector
Alector is a biotechnology company focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. Leveraging the principles of genetics, immunology, and neuroscience, the company is advancing a portfolio of programs that aim to remove toxic proteins, replace missing proteins, and restore immune and nerve cell function. Supported by biomarkers, Alector's product candidates seek to treat a range of indications, such as Alzheimer's disease and Parkinson's disease. The company is also developing Alector Brain Carrier (ABC), a proprietary blood-brain barrier platform, which is being applied to its preclinical and research pipeline. ABC aims to enhance the delivery of therapeutics, achieve deeper brain penetration and efficacy at lower doses, and ultimately improve patient outcomes while reducing costs. Alector is headquartered in South San Francisco, California. For more information, please visit www.alector.com.
Alector Contacts
Argot Partners (media)
David Rosen
646-461-6387
alector@argotpartners.com
Argot Partners (investors)
Laura Perry
212-600-1902
alector@argotpartners.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.